Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Raj

Showing results (381-390 of 454) with videos related to

Pageof 46
Sort By:
Kidney International|December 27, 2016
Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney diseaseJair Munoz Mendoza, Tamara Isakova, Xuan Cai, et al.
International Journal of Toxicology|February 28, 2026
Safety Assessment of Salvia officinalis (Sage)-Derived Ingredients as Used in CosmeticsPreethi S Raj, Wilma F Bergfeld, Donald V Belsito, et al.
International Journal of Toxicology|February 16, 2026
Safety Assessment of Fatty Ethers as Used in CosmeticsPreethi S Raj, Wilma F Bergfeld, Donald V Belsito, et al.
Plos One|April 25, 2015
Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC StudyJayanta Gupta, Elizabeth A Dominic, Jeffrey C Fink, et al.
Kidney360|April 4, 2024
Associations of Kidney Functional Magnetic Resonance Imaging Biomarkers with Markers of Inflammation in Individuals with CKDJacquelyn Trujillo, Manal Alotaibi, Nay Seif, et al.
Journal of the American Society of Nephrology : JASN|September 20, 2015
Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKDSankar D Navaneethan, Jason Roy, Kelvin Tao, et al.
Kidney International|November 27, 2018
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trialDavid M Charytan, Jonathan Himmelfarb, T Alp Ikizler, et al.
Circulation. Heart Failure|April 2, 2017
Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention TrialBharathi Upadhya, Michael Rocco, Cora E Lewis, et al.
Circulation. Heart Failure|November 26, 2021
Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINTBharathi Upadhya, James J Willard, Laura C Lovato, et al.
Plos One|February 4, 2016
Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC StudyRichard L Amdur, Monica Mukherjee, Alan Go, et al.
Pageof 46

Showing results (381-390 of 454) with videos related to

Sort By:
Pageof 46
Kidney International|December 27, 2016
Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney diseaseJair Munoz Mendoza, Tamara Isakova, Xuan Cai, et al.
International Journal of Toxicology|February 28, 2026
Safety Assessment of Salvia officinalis (Sage)-Derived Ingredients as Used in CosmeticsPreethi S Raj, Wilma F Bergfeld, Donald V Belsito, et al.
International Journal of Toxicology|February 16, 2026
Safety Assessment of Fatty Ethers as Used in CosmeticsPreethi S Raj, Wilma F Bergfeld, Donald V Belsito, et al.
Plos One|April 25, 2015
Association between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC StudyJayanta Gupta, Elizabeth A Dominic, Jeffrey C Fink, et al.
Kidney360|April 4, 2024
Associations of Kidney Functional Magnetic Resonance Imaging Biomarkers with Markers of Inflammation in Individuals with CKDJacquelyn Trujillo, Manal Alotaibi, Nay Seif, et al.
Journal of the American Society of Nephrology : JASN|September 20, 2015
Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKDSankar D Navaneethan, Jason Roy, Kelvin Tao, et al.
Kidney International|November 27, 2018
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trialDavid M Charytan, Jonathan Himmelfarb, T Alp Ikizler, et al.
Circulation. Heart Failure|April 2, 2017
Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention TrialBharathi Upadhya, Michael Rocco, Cora E Lewis, et al.
Circulation. Heart Failure|November 26, 2021
Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINTBharathi Upadhya, James J Willard, Laura C Lovato, et al.
Plos One|February 4, 2016
Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC StudyRichard L Amdur, Monica Mukherjee, Alan Go, et al.
Pageof 46